Asset
INTERFERON ALFA-N3
AIM ImmunoTech Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (0)
No records yet.
FDA applications (1)
| Application | Type | Applicant |
|---|---|---|
| BLA 103158 | BLA | AIM ImmunoTech Inc. |
Marketed products (1)
- ALFERON N INJECTION